Probably never. Nobody can. There is no system today that tells you whether a product you launched three years ago is still listed correctly across the NHS. Vima Access keeps eyes on every product in your portfolio, on a regular cycle, so you can answer that question on demand.
Brand teams move on to the next launch. Field teams focus on what’s new. The NHS systems, meanwhile, keep updating. Most of the time nothing important changes. When it does, nobody on your side is watching.
Vima Access is not a do-it-yourself audit tool. It is a platform plus a specialist team. The platform shows you what every NHS source has on file for each of your products. Our specialists verify, flag drift, and work alongside your market access lead when something needs putting right.
Every product on the platform shows its current state across every NHS source. dm+d names and identifiers, clinical-system listing state per pack, wholesaler catalogue status, Drug Tariff category and price. Each row dated, sourced, and verified.
When a clinical system flips your product to discontinued, a wholesaler delists a pack, or the Drug Tariff revises a price, the change surfaces on your dashboard with full context. Your MA lead sees what changed, when, and against what.
Our specialists draft NHSBSA queries, contact wholesalers and Optum on your behalf, and join calls with your team where needed. You stay in charge. We make you more effective. Two hours per SKU per year of pooled specialist time is included in every contract.
The platform watches automatically where the NHS publishes machine-readable data; our specialists verify everything else on a quarterly cycle. Two layers, one relationship.
We work with specialty pharma teams of every shape, from single-brand specialists to multi-brand portfolios. The model scales with your portfolio. The relationship looks the same.
A single brand or a small portfolio in one therapy area. We cover the whole portfolio with quarterly verification cycles, and our specialists handle the occasional NHSBSA query when something drifts.
Multi-SKU specialty pharma with regular launches and a steady base of mature products. Quarterly cycles across the whole portfolio plus weekly cycles on whatever is actively launching.
Larger portfolios spanning multiple brands or categories. Same model, scaled. Dedicated specialist allocation and bespoke escalation paths set up at onboarding.
Tell us which products you’d want to see and we’ll prepare a tailored demo with real data, typically within five working days.